Koyfin Home > Directory > Health Care > Biogen Inc > EBITDA / Interest Expenses

Biogen Inc EBITDA / Interest Expenses Chart (BIIB)

Biogen Inc annual/quarterly EBITDA / Interest Expenses from 2010 to 2020. EBITDA / Interest is the interest coverage ratio and measures the ability of a company to service its debt.
  • Biogen Inc EBITDA / Interest Expenses for the quarter ending September 09, 2020 was $22m a -87.38% decrease of -19m year over year
  • Biogen Inc EBITDA / Interest Expenses for the last 12 months ending September 09, 2020 was $36m a -16.91% decrease of -6m year over year
  • Biogen Inc Annual EBITDA / Interest Expenses for 2019 was $42m a 16.27% increase of 7m from 2018
  • Biogen Inc Annual EBITDA / Interest Expenses for 2018 was $35m a 24.65% increase of 9m from 2017
  • Biogen Inc Annual EBITDA / Interest Expenses for 2017 was $26m a 7.36% increase of 2m from 2016
Other Ratios Metrics:
  • Biogen Inc Total Debt / Capital for the quarter ending December 12, 2018 was $31m a 5.08% increase of 2m year over year
  • Biogen Inc Other Liabilities for the quarter ending December 12, 2018 was $3,026m a 1.80% increase of 55m year over year
  • Biogen Inc Total Debt / Equity for the quarter ending December 12, 2018 was $46m a 7.23% increase of 3m year over year
View Chart On Koyfin

Quarterly BIIB EBITDA / Interest Expenses Data

09/2020$22m
06/2020$38m
03/2020$46m
12/2019$40m
09/2019$45m
06/2019$44m
03/2019$37m
12/2018$37m
09/2018$41m
06/2018$28m

Annual BIIB EBITDA / Interest Expenses Data

2019$42m
2018$35m
2017$26m
2016$24m
2015$59m
2014$156m
2013$95m
2012$60m
2011$64m
2010$54m